Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
ASTRO 2024
Jun 28, 2024, 00:56 |
Blog
Mark Lewis: This is the football/oncology crossover I’m here for
Mark Lewis shared a post on X: “This is the football/oncology crossover I’m here for,…
Jun 27, 2024, 14:49 |
Societies
ESMOGI24 Presentations Summarized By Megan Barnet
ESMO GI 2024 is taking place as an onsite event in Munich, Germany, from 26 to 29…
Jun 27, 2024, 14:31 |
Societies
Keep up with ESMOGI24 with Teresa Macarulla
ESMO GI 2024 is taking place as an onsite event in Munich, Germany, from 26 to 29…
Jun 27, 2024, 11:18 |
Blog
FDA approves the targeted therapy adagrasib for people with advanced colorectal cancer - MSKCC
Memorial Sloan Kettering Cancer Center shared a post on LinkedIn: “The US Food and Drug…
Jun 27, 2024, 09:29 |
Blog
The LBAs for the ESMOGI24 are now live
ESMO shared on X: "The LBAs for the ESMO Gastrointestinal Cancers Congress 2024 are now live.…
Jun 27, 2024, 08:20 |
Societies
Insights from ESMOGI24 by Angela Lamarca
ESMO GI 2024 is taking place as an onsite event in Munich, Germany, from 26…
Jun 26, 2024, 16:21 |
Insight
Lumír Kunovský: Pancreas2000 project
Recently Lumír Kunovský, Associate Professor at the University Hospital Brno, shared a post on X…
Jun 26, 2024, 14:17 |
Blog
Analysis of post-hoc of CAIRO5
Arndt Vogel shared on X: "Prognostic value of total tumor volume in CRC liver metastases.…
Jun 26, 2024, 13:47 |
Societies
177Lu-DOTATATE as a frontline treatment for somatostatin receptor-positive grade 3 low GEP-NETs
ESMO shared on LinkedIn: "ESMOGI24: Promising data from the phase III NETTER-2 study show that…
Jun 26, 2024, 08:30 |
Insight
IMFINZI (durvalumab) showed improved EFS and OS for MIBC in NIAGARA Phase III trial
First immunotherapy regimen before and after surgery to extend survival in bladder cancer Positive high-level results…
31
32
33
34
35
All:
547
Posts:
321 - 330
Top 100 Xfluencers in Pediatric Hematology/Oncology: Key Opinion Leaders to follow on X (Twitter) in 2024
Jeff Bridges and Lymphoma: How He Went Against, How He Survived, and More
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 5
Familial Adenomatous Polyposis: Alarming Symptoms, Causes, Types, Diagnosis and Treatment
OncoDaily Party Barcelona
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube